Detalhe da pesquisa
1.
Efficacy of early transfusion of convalescent plasma with high-titer SARS-CoV-2 neutralizing antibodies in hospitalized patients with COVID-19.
Transfusion
; 62(5): 974-981, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338710
2.
Convalescent plasma for SARS-CoV-2 infection: win or learn.
Eur Respir J
; 59(2)2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34531275
3.
High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial.
Lancet Respir Med
; 10(3): 278-288, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150610
4.
Relationship between the ABO blood group and COVID-19 susceptibility, severity and mortality in two cohorts of patients.
Blood Transfus
; 19(1): 54-63, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33196417
5.
SARS-CoV-2/COVID-19 pandemic: first wave, impact, response and lessons learnt in a fully integrated Regional Blood and Tissue Bank. A narrative report.
Blood Transfus
; 19(2): 158-167, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539280